Finally, a schematic model (Figure 5I) summarizes our findings, suggesting that complement activation, particularly through C3, enhances the expression of inflammatory markers such as IL6 and CRP, thereby contributing to the inflammatory milieu associated with PCOS. The gene discussed is IL6; the disease is polycystic ovary syndrome.